2002
DOI: 10.1016/s0960-894x(02)00207-x
|View full text |Cite
|
Sign up to set email alerts
|

Structure–Activity studies for a novel series of tricyclic dihydropyrimidines as KATP channel openers (KCOs)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
47
0
3

Year Published

2002
2002
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 65 publications
(50 citation statements)
references
References 9 publications
0
47
0
3
Order By: Relevance
“…Several compounds of this class display interesting antitrypanosomal [4] and antischistosomal activities [6]. They are used as HMG-CoA reductaseinhibitors [7], COX-2 selective inhibitors [8], 30,50-cyclic-AMP phosphodiesteraseinhibitors [9], CRF1 antagonists [10][11], selective peripheral benzodiazepine receptor ligands [12][13][14][15][16], potassium channel [17] and histamine-3 receptor ligands [18], CDK9 inhibitor [19]and antianxiety agents [20].…”
Section: Introductionmentioning
confidence: 99%
“…Several compounds of this class display interesting antitrypanosomal [4] and antischistosomal activities [6]. They are used as HMG-CoA reductaseinhibitors [7], COX-2 selective inhibitors [8], 30,50-cyclic-AMP phosphodiesteraseinhibitors [9], CRF1 antagonists [10][11], selective peripheral benzodiazepine receptor ligands [12][13][14][15][16], potassium channel [17] and histamine-3 receptor ligands [18], CDK9 inhibitor [19]and antianxiety agents [20].…”
Section: Introductionmentioning
confidence: 99%
“…[3,4] Среди дигидропиразоло[1,5-a] пиримидинов обнаружен ряд эффективных модулято-ров Ca-и K-каналов. [5][6][7][8][9][10] Триазоло[1,5-a]пиримидины оказались перспективными антагонистами аденозин A 2A рецептора при лечении болезни Паркинсона. [11] Не-которые дигидротриазоло [1,5-a]пиримидины проявили антиконвульсантную на уровне Карбамазепина [12] и анти-пролиферативную [13] клеточную активность.…”
Section: Introductionunclassified
“…-дибензо [13,14:8,9] [1,4,7]триоксацикло-тетрадецино [11,10-e]азоло [1,5-a] Azolo [1,5-a]pyrimidines are considered to be purine analogues and they form one of the most promising groups of biologically active compounds [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16] in medicinal chemistry. One of the strategies enhancing biochemical activity of azolo [1,5-a]pyrimidines is introduction of functional groups responsible for solubility and transport into their pharmacophore nucleus.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…There are literary data about the synthesis of triazolopyrimidines by treatment of 5-amino-1,2,4-triazole or 5-aminotetrazole with aldehydes and ethyl acetoacetate or cyclic -diketones [7][8][9][10][11]. The cyclocondensations were realized by heating of the starting materials in ethanol with catalytic amounts of hydrochloric acid under reflux conditions [7][8][9] or using DMF as solvent [10][11].…”
Section: Introductionmentioning
confidence: 99%